Bright Health Group, Inc.

NYSE:BHG

16.35 (USD) • At close January 26, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 215.78776.405232.933225.991292.871269.399297.982756.341551.4251,632.2921,576.6281,835.575962.3341,078.6571,113.84874.558359.778352.12296.856198.566
Cost of Revenue 160.894-59.763246.768247.898330.305226.438245.16688.515519.2911,456.8621,398.1661,580.5962,604.6591,050.943904.63684.57372.186311.319233.18130.615
Gross Profit 54.893136.168-13.835-21.907-37.43442.96152.82267.82632.134175.43178.462254.979-1,642.32527.714209.21189.988-12.40840.80163.67667.951
Gross Profit Ratio 0.2541.782-0.059-0.097-0.1280.1590.1770.090.0580.1070.1130.139-1.7070.0260.1880.217-0.0340.1160.2150.342
Reseach & Development Expenses 00000000000000000000
General & Administrative Expenses 0129.8900065.9463.95108.869-173.456221.904213.805239.588248.644161.545119.68296.48965.77956.33346.87142.766
Selling & Marketing Expenses 0-0.8880000.2580.6320.344-167.11877.72179.9391.807104.11969.44363.98850.20557.88615.94114.4748.64
SG&A 0130.77800066.19864.58129.213-340.574299.625293.735331.395352.763230.988183.67146.694123.66572.27461.34551.406
Other Expenses 213.126400.462250.275263.54338.806732.174321.39621.002536.70711.724132.814100.5641,782.3311.22684.58566.12727.75827.78329.56723.825
Operating Expenses 213.126531.24250.275263.54338.80699.0774.951150.215196.133311.349426.549431.9591,782.331323.995268.255212.821151.423100.05790.91275.231
Operating Income 2.661446.958-26.007-39.259-62.827-462.775-23.414-82.389-163.999-135.919-248.087-176.98-819.997-296.281-59.045-22.833-163.831-59.256-27.236-7.28
Operating Income Ratio 0.0125.85-0.112-0.174-0.215-1.718-0.079-0.109-0.297-0.083-0.157-0.096-0.852-0.275-0.053-0.026-0.455-0.168-0.092-0.037
Total Other Income Expenses Net -3.98830.0922.793-0.187-2.073-426.581-0.8921.259-115.483-121.679-179.7-80.569-856.903-0.368-4.142-0.546-3.8000
Income Before Tax -1.327477.05-23.214-39.446-61.237-482.69-32.584-93.533-192.462-257.598-248.426-177.389-821.671-296.649-63.187-23.379-163.831-59.256-27.236-7.28
Income Before Tax Ratio -0.0066.244-0.1-0.175-0.209-1.792-0.109-0.124-0.349-0.158-0.158-0.097-0.854-0.275-0.057-0.027-0.455-0.168-0.092-0.037
Income Tax Expense 0.1115.2842.793-0.1871.59-3.385-0.8921.259-4.2281.7632.9043.24-8.2960.073-19.4641.1660.0010-9.1623.009
Net Income -24.875802.729-70.475-71.39-242.332-633.895-112.832-94.792-188.234-259.361-251.33-180.629-813.375-300.664-44.518-25.162-163.832-59.256-18.074-7.28
Net Income Ratio -0.11510.506-0.303-0.316-0.827-2.353-0.379-0.125-0.341-0.159-0.159-0.098-0.845-0.279-0.04-0.029-0.455-0.168-0.061-0.037
EPS -2.9101.46-8.51-8.65-30.47-79.47-14.17-12.01-23.97-32.95-31.96-22.9827.65-38.16-22.13-14.36-95.67-34.77-10.65-4.25
EPS Diluted -2.9101.46-8.51-8.65-30.47-79.47-14.17-12.01-23.97-32.95-31.96-22.9827.65-38.16-22.13-14.36-95.67-34.77-10.65-4.25
EBITDA -14.568797.662-58.765-63.489-225.512-51.986-15.994-72.498-153.597-122.013-234.86-163.155-810.494-280.85-51.85-18.252-161.092-56.578-25.151-6.493
EBITDA Ratio -0.06810.44-0.252-0.281-0.77-0.193-0.054-0.096-0.279-0.075-0.149-0.089-0.842-0.26-0.047-0.021-0.448-0.161-0.085-0.033